http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103884839-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-09
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
filingDate 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103884839-B
titleOfInvention A kind of reverse LPB-ELISA method for quantitatively detecting FMDV Effective Antigens
abstract The invention discloses a kind of reverse LPB-ELISA method for quantitatively detecting FMDV Effective Antigens.The present invention is by fixing the dilution process of standard positive serum, namely the amount of serum antibody is fixed, antigen to be checked is made serial dilution act on it, the standard control antigen of known effective antigenic content is set simultaneously, based on positive serum under a certain constant antibody titer its 50% to block Effective Antigens amount be this certain antigen-antibody reaction principle, successfully establish a kind of new technology quantitative to foot and mouth disease virus Effective Antigens, the reverse LPB-ELISA of called after.Separable when the method inherits LPB-ELISA method for measuring serum antibody, simple to operate, reproducible, hypersensitivity, high specific, can the advantage such as batch detection, achieving the quantitative measurement of the Effective Antigens amount to FMDV simultaneously, providing technological means for solving the vaccine potency inspection animal substitution problem being badly in need of now solving both at home and abroad.
priorityDate 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1609870-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22734939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449046755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524

Total number of triples: 23.